Cargando…
Multiplex detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS assay
Molecular diagnostic testing of KRAS and BRAF mutations has become critical in the management of colorectal cancer (CRC) patients. Some progress has been made in liquid biopsy detection of mutations in circulating tumor DNA (ctDNA), which is a fraction of circulating cell-free DNA (cfDNA), but slow...
Autores principales: | Lyu, Nana, Rajendran, Vinoth Kumar, Diefenbach, Russell J., Charles, Kellie, Clarke, Stephen J., Engel, Alexander, Rizos, Helen, Molloy, Mark P., Wang, Yuling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484630/ https://www.ncbi.nlm.nih.gov/pubmed/32923312 http://dx.doi.org/10.7150/ntno.48905 |
Ejemplares similares
-
SERS characterization of colorectal cancer cell surface markers upon anti‐EGFR treatment
por: Lyu, Nana, et al.
Publicado: (2022) -
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors
por: Zhao, Jianhua, et al.
Publicado: (2023) -
Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
por: Diefenbach, Russell J., et al.
Publicado: (2022) -
Role of ctDNA in Breast Cancer
por: Sant, Marta, et al.
Publicado: (2022) -
The Role of ctDNA in Gastric Cancer
por: Mencel, Justin, et al.
Publicado: (2022)